- Revenue: $943 million, +8% YoY, with CooperVision at $636 million (+11% YoY) and CooperSurgical at $307 million (+4% YoY).
- Gross Profit: $580.9 million with a gross margin of 61.6%, up from 61.5% in the previous year.
- Operating Income: $161.7 million, improving operating margin to 17.2%.
- Net Income: $88.9 million, reflecting a 123% increase YoY.
- EPS: $0.45 reported, $0.85 on a non-GAAP basis, +10% YoY.
- Free Cash Flow: $37 million with capital expenditures of $74 million.
- Debt: Reduced net debt to $2.6 billion.
- Effective Tax Rate: 13.5%, positively impacted by stock option exercises, expected to remain around 14% for the year.